Cough Assist Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Automatic v/s Manual), By Choice of Delivery (Face Mask, Mouthpiece, Adapter), By End User (Hospitals & Clinics, Ambulatory Care Settings, Homecare, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.11 Billion
CAGR (2026-2031)	7.76%
Fastest Growing Segment	Automatic
Largest Market	North America
Market Size (2031)	USD 4.87 Billion

Market Overview

The Global Cough Assist Devices Market is projected to grow from USD 3.11 Billion in 2025 to USD 4.87 Billion by 2031 at a 7.76% CAGR. Cough assist devices, also known as mechanical insufflation-exsufflation devices, are specialized respiratory care tools designed to clear airway secretions in patients with impaired natural cough ability. These devices achieve this by applying positive pressure to inflate the lungs, followed by a rapid shift to negative pressure to simulate a strong exhalation, effectively mobilizing and removing mucus. The primary drivers supporting market growth include the increasing prevalence of chronic respiratory disorders such as Chronic Obstructive Pulmonary Disease and cystic fibrosis, the rising incidence of neuromuscular diseases like muscular dystrophy and spinal cord injuries that weaken respiratory muscles, and the expanding global geriatric population more susceptible to respiratory ailments. The shift towards home healthcare settings also fuels demand for these non-invasive airway clearance solutions.

A significant challenge impeding market expansion is the elevated acquisition cost of these advanced devices, which can present a barrier for many healthcare providers and individual patients. Moreover, limited or inconsistent reimbursement policies across various regions contribute to patient and institutional financial burdens, potentially restricting broader adoption. According to MedTech Europe, the European medical technology market, a broader category encompassing various medical devices, was estimated at approximately €170 billion in 2024.

Key Market Drivers

The increasing prevalence of chronic respiratory and neuromuscular disorders is a primary catalyst for the global cough assist devices market. Conditions such as Chronic Obstructive Pulmonary Disease, cystic fibrosis, muscular dystrophy, and spinal cord injuries impair natural cough reflexes, necessitating external airway clearance. Cough assist devices provide vital mechanical insufflation-exsufflation to mobilize and remove secretions, preventing complications and improving patient quality of life. According to a Global Burden of Disease analysis, reported in Nature Medicine, January 2026, nearly 570 million people worldwide were living with a chronic respiratory disease in 2023. This significant patient pool represents a substantial and growing demand for effective airway clearance solutions.

Furthermore, the aging global population demographics exert considerable influence on market expansion. Older adults are inherently more susceptible to respiratory ailments and have a higher likelihood of developing chronic conditions that compromise cough effectiveness. As the proportion of elderly individuals increases worldwide, so does the population at risk for impaired airway clearance. According to United Nations population projections, in 2024, the worldwide share of people aged 65 had reached 10.3 percent, demonstrating the demographic shift towards an older populace. The sustained need for respiratory support in this demographic significantly drives the adoption of cough assist devices. According to Fisher & Paykel Healthcare Corporation Limited, in 2025, the company reported total operating revenue of $2.02 billion for the full year ended March 31, 2025, reflecting robust performance in segments inclusive of respiratory care.

Download Free Sample Report

Key Market Challenges

The elevated acquisition cost of cough assist devices presents a notable impediment to market expansion. These specialized respiratory care tools, while crucial for patients with impaired natural cough ability, represent a substantial capital expenditure for many healthcare providers and individual patients. This high upfront investment can limit procurement, particularly in healthcare systems operating under stringent budget constraints or in regions with lower per-capita healthcare spending.

The financial burden directly impacts the accessibility and broader adoption of these advanced devices. According to AdvaMed's Q4 2025 Report, published in January 2026, over 360 public comments were submitted in support of AdvaMed's position, warning that tariff-induced cost increases for medical technologies would disrupt patient access and the medical technology supply chain. This demonstrates a broad industry consensus that escalating costs directly translate into barriers for patients accessing necessary medical devices, thereby restricting the wider deployment and market growth for advanced equipment like cough assist devices. The necessity for significant investment limits the ability of many healthcare facilities to acquire and integrate these devices into their standard care protocols.

Key Market Trends

Innovation in device miniaturization and the development of user-friendly interfaces represent a significant trend reshaping the global cough assist devices market. This trend is driven by a broader industry push toward making medical technologies more portable, less intrusive, and simpler for both patients and caregivers to operate, especially in non-clinical settings. Such advancements enhance patient adherence to therapy and improve overall quality of life by enabling easier integration of devices into daily routines. This focus on design and usability encourages investment in research and development within the broader medical technology sector; according to Medical Product Outsourcing, January 2026, Ireland saw a record level of future research, development, and innovation investment commitments totaling €2.5 billion by IDA Ireland clients in 2025, reflecting a wider commitment to product development and emerging technologies.

The integration of telehealth and remote monitoring capabilities is another crucial trend profoundly influencing the cough assist devices market. This shift allows healthcare providers to remotely track patient adherence, device usage, and critical physiological parameters, facilitating timely interventions and personalized care adjustments without the need for frequent in-person visits. For patients with chronic respiratory conditions, remote monitoring offers enhanced convenience and continuous oversight, which can lead to improved long-term outcomes and reduced hospitalization rates. This interconnected approach extends the reach of specialized respiratory care beyond traditional clinical boundaries. Illustrating this expansion, ResMed Inc. reported in its Q2 FY26 results, January 2026, that it manages over 35 million patients through its AirView platform, underscoring the substantial adoption and impact of connected health solutions in respiratory care.

Segmental Insights

The Automatic segment is demonstrating rapid growth within the Global Cough Assist Devices Market, primarily driven by continuous technological advancements. This expansion is attributed to the enhanced programmability and user-friendliness of automatic devices, which significantly improve ease of use and patient comfort compared to manual alternatives. The efficiency of these advanced non-intrusive airway clearance solutions in mobilizing secretions contributes to better patient outcomes. Furthermore, increasing adoption in home care settings, supported by their portability and user-centric design, along with growing awareness and favorable reimbursement policies by institutions such as the Centers for Medicare and Medicaid Services (CMS) in some regions, are accelerating this segment's trajectory.

Regional Insights

North America leads the global cough assist devices market, primarily due to the significant prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis, and various neuromuscular disorders, which necessitate advanced airway clearance solutions. The region benefits from a robust healthcare infrastructure, ensuring broad access to sophisticated medical technologies and skilled personnel. Furthermore, favorable reimbursement policies from both governmental and private entities substantially support the adoption and utilization of these devices. The presence of numerous key market players also drives continuous innovation and product development, contributing to the region's strong market position.

Recent Developments

• In April 2026, C-mo Medical Solutions announced that its AI-powered cough monitoring solution, the C-mo System, received CE Mark approval under EU MDR 2017/745. This non-invasive Class IIa medical device was approved for monitoring cough across a broad range of indications, including pediatric, adult, and elderly patient populations. The certification covered the biosensor, automated cough monitoring algorithms, and the accompanying software platform, enabling precise and objective measurement of cough frequency, bouts, and intensity. This regulatory milestone for a new product launch is expected to support broader adoption of advanced cough assessment technologies within the Global Cough Assist Devices Market.
• In February 2026, Sibel Health, a developer of medical-grade wearable sensor technology, received acceptance from the U.S. Food and Drug Administration (FDA) into the Clinical Outcome Assessment Qualification Program. This milestone pertained to the company’s novel Cough Monitoring sensor, known as the Aria sensor, for advancing objective cough frequency measurement in adult patients with chronic refractory cough. The Aria sensor was designed to objectively and privately capture coughing events through advanced acousto-mechanic sensing without recording identifiable speech. This breakthrough research marked a significant step in developing accurate and privacy-preserving tools for cough assessment, influencing future innovations in the Global Cough Assist Devices Market.
• In August 2025, ABM Respiratory Care, a global medical technology company, in collaboration with its exclusive distribution partner McArthur Medical Sales Inc., announced the nationwide launch of its BiWaze® Cough system in Canada. This next-generation assisted-cough system was designed to enhance secretion clearance for patients experiencing weak or ineffective coughs. The device incorporates a dual-blower with a dual-lumen breathing circuit, separating inhaled and exhaled airflows to improve hygiene and efficacy. This launch expanded the availability of advanced respiratory care solutions within the Global Cough Assist Devices Market, providing clinicians and patients across Canada with access to innovative therapy and local support.
• In January 2025, ActiGraph, a U.S.-based provider of physical activity and sleep-monitoring technologies, partnered with Hyfe Inc. to integrate AI-driven cough detection into its LEAP wearable device. This collaboration aimed to introduce a continuous and privacy-conscious digital health tool for objectively monitoring cough over extended periods within clinical research settings. The partnership sought to advance research by enabling the collection of accurate, continuous cough frequency data alongside other digital measures. This breakthrough research enhanced the capabilities for comprehensive cough assessment, a critical component for developing and evaluating solutions in the Global Cough Assist Devices Market.

Key Market Players

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• Hayek Medical
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

By Type	By Choice of Delivery	By End User	By Region
Automatic v/s Manual	Face Mask Mouthpiece Adapter	Hospitals & Clinics Ambulatory Care Settings Homecare Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cough Assist Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cough Assist Devices Market, By Type:

• Automatic v/s Manual

• Cough Assist Devices Market, By Choice of Delivery:

• Face Mask
• Mouthpiece
• Adapter

• Cough Assist Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Settings
• Homecare
• Others

• Cough Assist Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE